UNIverse - Public Research Portal

[FG] Tschudin Sutter Sarah

Research Group Sarah Tschudin Sutter

Research Focus

Immunology & Infectious Diseases


Area of Research

Hospital acquired infections, with a focus on transmission of multi drug-resistant pathogens, and infection prevention and control interventions.


Approved Research Projects

  • Transmission of ESBL-producing Enterobacteriaceae (ClinicalTrials.gov Identifier: NCT03465683)
  • Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital (ClinicalTrials.gov Identifier: NCT04098133)
  • SIMPLIFY the Hand Hygiene Procedure - Three Steps Versus Six Steps for Performing Hand Hygiene (SIMPLIFY Study) (ClinicalTrials.gov Identifier: NCT04187040)


Collaborations

National Collaborations

  • ANRESIS, Swiss Centre for Antibiotic Resistance, Bern
  • Department of Clinical Bacteriology and Mycology, University Hospital Basel
  • Cantonal Laboratory of the City of Basel
  • Department of Biosystems and Engineering Sciences at ETH Zurich
  • National Center for Infection Prevention (Swissnoso)
  • Swiss Society for Infectious Diseases (SSI)
  • Swiss Society for Hospital Hygiene (SGSH)
  • Swiss Antibiogram Committee (SAC), Swiss Society for Microbiology
  • Federal Office of Public Health (FOPH)


International Collaborations

  • European Working Group for C. difficile (ESCMID Study Group for C. difficile)
  • Guideline Subcommittee European Society of Clinical Microbiology and Infectious Diseases (ESCMID)


Ongoing Research Projects

  • Transmission of ESBL-producing Enterobacteriaceae (ClinicalTrials.gov Identifier: NCT03465683)
  • Simplifying the World Health Organization (WHO) Protocol for Hand Hygiene (ClinicalTrials.gov Identifier: NCT03588221)
  • Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital (ClinicalTrials.gov Identifier: NCT04098133)
  • AntiResist: New approaches to combat antibiotic-resistant bacteria (ClinicalTrials.gov Identifier: NCT05017766)
  • Fecal microbiota transplantation versus vancomycin or fidaxomicin in Clostridioides difficile infection first recurrence (FENDER) (ClinicalTrials.gov Identifier: NCT05266807)